Innovent Biologics Inc. (IVBXF)
PNK: IVBXF
· Real-Time Price · USD
6.88
0.91 (15.15%)
At close: May 01, 2025, 12:59 PM
Innovent Biologics Revenue
Innovent Biologics reported an annual revenue of $6.21B, reflecting a 36.21% growth. For the quarter ending June 30, 2024, Innovent Biologics generated $3.95B in revenue.
Revenue (ttm)
$6.21B
Revenue Growth
36.21%
Price / Sales Ratio
8.76
Revenue / Employee
$1.1M
Employees
5,659
Market Cap
11.26B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | % Change |
|---|---|---|
| Dec 31, 2023 | 6.21B | +36.21% |
| Dec 31, 2022 | 4.56B | +6.71% |
| Dec 31, 2021 | 4.27B | +11.08% |
| Dec 31, 2020 | 3.84B | n/a |